UniProt ID | IWS1_HUMAN | |
---|---|---|
UniProt AC | Q96ST2 | |
Protein Name | Protein IWS1 homolog | |
Gene Name | IWS1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 819 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor which plays a key role in defining the composition of the RNA polymerase II (RNAPII) elongation complex and in modulating the production of mature mRNA transcripts. Acts as an assembly factor to recruit various factors to the RNAPII elongation complex and is recruited to the complex via binding to the transcription elongation factor SUPT6H bound to the C-terminal domain (CTD) of the RNAPII subunit RPB1 (POLR2A). The SUPT6H:IWS1:CTD complex recruits mRNA export factors (ALYREF/THOC4, EXOSC10) as well as histone modifying enzymes (such as SETD2) to ensure proper mRNA splicing, efficient mRNA export and elongation-coupled H3K36 methylation, a signature chromatin mark of active transcription.. | |
Protein Sequence | MDSEYYSGDQSDDGGATPVQDERDSGSDGEDDVNEQHSGSDTGSVERHSENETSDREDGLPKGHHVTDSENDEPLNLNASDSESEELHRQKDSDSESEERAEPPASDSENEDVNQHGSDSESEETRKLPGSDSENEELLNGHASDSENEDVGKHPASDSEIEELQKSPASDSETEDALKPQISDSESEEPPRHQASDSENEEPPKPRMSDSESEELPKPQVSDSESEEPPRHQASDSENEELPKPRISDSESEDPPRHQASDSENEELPKPRISDSESEDPPRNQASDSENEELPKPRVSDSESEGPQKGPASDSETEDASRHKQKPESDDDSDRENKGEDTEMQNDSFHSDSHMDRKKFHSSDSEEEEHKKQKMDSDEDEKEGEEEKVAKRKAAVLSDSEDEEKASAKKSRVVSDADDSDSDAVSDKSGKREKTIASDSEEEAGKELSDKKNEEKDLFGSDSESGNEEENLIADIFGESGDEEEEEFTGFNQEDLEEEKGETQVKEAEDSDSDDNIKRGKHMDFLSDFEMMLQRKKSMSGKRRRNRDGGTFISDADDVVSAMIVKMNEAAEEDRQLNNQKKPALKKLTLLPAVVMHLKKQDLKETFIDSGVMSAIKEWLSPLPDRSLPALKIREELLKILQELPSVSQETLKHSGIGRAVMYLYKHPKESRSNKDMAGKLINEWSRPIFGLTSNYKGMTREEREQRDLEQMPQRRRMNSTGGQTPRRDLEKVLTGEEKALRPGDPGFCARARVPMPSNKDYVVRPKWNVEMESSRFQATSKKGISRLDKQMRKFTDIRKKSRSAHAVKISIEGNKMPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDSEYYSG -------CCCCCCCC | 13.28 | 22814378 | |
3 | Phosphorylation | -----MDSEYYSGDQ -----CCCCCCCCCC | 26.63 | 27732954 | |
3 (in isoform 2) | Phosphorylation | - | 26.63 | 24043423 | |
5 | Phosphorylation | ---MDSEYYSGDQSD ---CCCCCCCCCCCC | 13.59 | 23663014 | |
5 (in isoform 2) | Phosphorylation | - | 13.59 | 24043423 | |
6 | Phosphorylation | --MDSEYYSGDQSDD --CCCCCCCCCCCCC | 11.35 | 23663014 | |
6 (in isoform 2) | Phosphorylation | - | 11.35 | 24043423 | |
7 | Phosphorylation | -MDSEYYSGDQSDDG -CCCCCCCCCCCCCC | 34.68 | 23663014 | |
7 (in isoform 2) | Phosphorylation | - | 34.68 | 24043423 | |
11 | Phosphorylation | EYYSGDQSDDGGATP CCCCCCCCCCCCCCC | 42.27 | 23663014 | |
11 (in isoform 2) | Phosphorylation | - | 42.27 | 24043423 | |
17 | Phosphorylation | QSDDGGATPVQDERD CCCCCCCCCCCCCCC | 27.54 | 20363803 | |
17 (in isoform 2) | Phosphorylation | - | 27.54 | 24043423 | |
23 (in isoform 2) | Phosphorylation | - | 52.24 | 24043423 | |
25 | Phosphorylation | PVQDERDSGSDGEDD CCCCCCCCCCCCCCC | 46.55 | 22167270 | |
25 (in isoform 3) | Phosphorylation | - | 46.55 | 22210691 | |
26 (in isoform 2) | Phosphorylation | - | 33.76 | 24043423 | |
27 | Phosphorylation | QDERDSGSDGEDDVN CCCCCCCCCCCCCCC | 46.52 | 23401153 | |
27 (in isoform 3) | Phosphorylation | - | 46.52 | 22210691 | |
28 (in isoform 2) | Phosphorylation | - | 68.94 | 24043423 | |
38 | Phosphorylation | DDVNEQHSGSDTGSV CCCCCCCCCCCCCCC | 39.42 | 23663014 | |
40 | Phosphorylation | VNEQHSGSDTGSVER CCCCCCCCCCCCCCC | 34.71 | 25849741 | |
42 | Phosphorylation | EQHSGSDTGSVERHS CCCCCCCCCCCCCCC | 32.81 | 23663014 | |
44 | Phosphorylation | HSGSDTGSVERHSEN CCCCCCCCCCCCCCC | 23.93 | 25849741 | |
49 | Phosphorylation | TGSVERHSENETSDR CCCCCCCCCCCCCCC | 48.62 | 29255136 | |
49 (in isoform 3) | Phosphorylation | - | 48.62 | 22210691 | |
53 | Phosphorylation | ERHSENETSDREDGL CCCCCCCCCCCCCCC | 47.73 | 23401153 | |
53 (in isoform 3) | Phosphorylation | - | 47.73 | 26657352 | |
54 | Phosphorylation | RHSENETSDREDGLP CCCCCCCCCCCCCCC | 28.61 | 29255136 | |
54 (in isoform 3) | Phosphorylation | - | 28.61 | 26657352 | |
56 (in isoform 3) | Phosphorylation | - | 43.61 | 22210691 | |
67 | Phosphorylation | LPKGHHVTDSENDEP CCCCCCCCCCCCCCC | 29.47 | 30266825 | |
67 (in isoform 3) | Phosphorylation | - | 29.47 | 29743597 | |
69 | Phosphorylation | KGHHVTDSENDEPLN CCCCCCCCCCCCCCC | 29.00 | 24300666 | |
80 | Phosphorylation | EPLNLNASDSESEEL CCCCCCCCCHHHHHH | 40.36 | 24300666 | |
82 | Phosphorylation | LNLNASDSESEELHR CCCCCCCHHHHHHHH | 40.29 | 24300666 | |
84 | Phosphorylation | LNASDSESEELHRQK CCCCCHHHHHHHHHC | 40.08 | 30266825 | |
93 | Phosphorylation | ELHRQKDSDSESEER HHHHHCCCCCCCHHH | 50.50 | 28985074 | |
95 | Phosphorylation | HRQKDSDSESEERAE HHHCCCCCCCHHHCC | 47.15 | 28176443 | |
97 | Phosphorylation | QKDSDSESEERAEPP HCCCCCCCHHHCCCC | 49.02 | 28176443 | |
106 | Phosphorylation | ERAEPPASDSENEDV HHCCCCCCCCCCCCH | 47.66 | 17081983 | |
108 | Phosphorylation | AEPPASDSENEDVNQ CCCCCCCCCCCCHHH | 39.56 | 16565220 | |
118 | Phosphorylation | EDVNQHGSDSESEET CCHHHCCCCCCCHHH | 35.52 | 28985074 | |
120 | Phosphorylation | VNQHGSDSESEETRK HHHCCCCCCCHHHCC | 44.73 | 24461736 | |
122 | Phosphorylation | QHGSDSESEETRKLP HCCCCCCCHHHCCCC | 44.69 | 17081983 | |
131 | Phosphorylation | ETRKLPGSDSENEEL HHCCCCCCCHHCHHH | 35.70 | 22115753 | |
133 | Phosphorylation | RKLPGSDSENEELLN CCCCCCCHHCHHHHC | 43.98 | 16565220 | |
144 | Phosphorylation | ELLNGHASDSENEDV HHHCCCCCCCCCCCC | 35.67 | 22115753 | |
146 | Phosphorylation | LNGHASDSENEDVGK HCCCCCCCCCCCCCC | 39.56 | 26055452 | |
157 | Phosphorylation | DVGKHPASDSEIEEL CCCCCCCCHHHHHHH | 46.23 | 29255136 | |
159 | Phosphorylation | GKHPASDSEIEELQK CCCCCCHHHHHHHHH | 37.67 | 26503892 | |
167 | Phosphorylation | EIEELQKSPASDSET HHHHHHHCCCCCCCC | 16.85 | 20873877 | |
170 | Phosphorylation | ELQKSPASDSETEDA HHHHCCCCCCCCHHH | 45.08 | 25159151 | |
172 | Phosphorylation | QKSPASDSETEDALK HHCCCCCCCCHHHHC | 43.87 | 25159151 | |
174 | Phosphorylation | SPASDSETEDALKPQ CCCCCCCCHHHHCCC | 43.02 | 20873877 | |
183 | Phosphorylation | DALKPQISDSESEEP HHHCCCCCCCCCCCC | 29.81 | 21082442 | |
185 | Phosphorylation | LKPQISDSESEEPPR HCCCCCCCCCCCCCC | 35.91 | 28985074 | |
187 | Phosphorylation | PQISDSESEEPPRHQ CCCCCCCCCCCCCCC | 51.73 | 20873877 | |
196 | Phosphorylation | EPPRHQASDSENEEP CCCCCCCCCCCCCCC | 34.79 | 29255136 | |
198 | Phosphorylation | PRHQASDSENEEPPK CCCCCCCCCCCCCCC | 39.56 | 29255136 | |
198 | Ubiquitination | PRHQASDSENEEPPK CCCCCCCCCCCCCCC | 39.56 | 24816145 | |
209 | Phosphorylation | EPPKPRMSDSESEEL CCCCCCCCCCCCCCC | 38.98 | 25159151 | |
211 | Phosphorylation | PKPRMSDSESEELPK CCCCCCCCCCCCCCC | 35.40 | 25159151 | |
213 | Phosphorylation | PRMSDSESEELPKPQ CCCCCCCCCCCCCCC | 40.08 | 25022875 | |
222 | Phosphorylation | ELPKPQVSDSESEEP CCCCCCCCCCCCCCC | 30.12 | 21082442 | |
224 | Phosphorylation | PKPQVSDSESEEPPR CCCCCCCCCCCCCCC | 35.20 | 21082442 | |
226 | Phosphorylation | PQVSDSESEEPPRHQ CCCCCCCCCCCCCCC | 51.73 | 25022875 | |
235 | Phosphorylation | EPPRHQASDSENEEL CCCCCCCCCCCCCCC | 34.79 | 29255136 | |
237 | Phosphorylation | PRHQASDSENEELPK CCCCCCCCCCCCCCC | 39.56 | 29255136 | |
248 | Phosphorylation | ELPKPRISDSESEDP CCCCCCCCCCCCCCC | 36.04 | 29255136 | |
250 | Phosphorylation | PKPRISDSESEDPPR CCCCCCCCCCCCCCC | 35.91 | 29255136 | |
252 | Phosphorylation | PRISDSESEDPPRHQ CCCCCCCCCCCCCCC | 51.78 | 29255136 | |
261 | Phosphorylation | DPPRHQASDSENEEL CCCCCCCCCCCCCCC | 34.79 | 29255136 | |
263 | Phosphorylation | PRHQASDSENEELPK CCCCCCCCCCCCCCC | 39.56 | 29255136 | |
274 | Phosphorylation | ELPKPRISDSESEDP CCCCCCCCCCCCCCC | 36.04 | 29255136 | |
276 | Phosphorylation | PKPRISDSESEDPPR CCCCCCCCCCCCCCC | 35.91 | 29255136 | |
278 | Phosphorylation | PRISDSESEDPPRNQ CCCCCCCCCCCCCCC | 51.78 | 29255136 | |
287 | Phosphorylation | DPPRNQASDSENEEL CCCCCCCCCCCCCCC | 31.72 | 29255136 | |
289 | Phosphorylation | PRNQASDSENEELPK CCCCCCCCCCCCCCC | 39.56 | 29255136 | |
300 | Phosphorylation | ELPKPRVSDSESEGP CCCCCCCCCCCCCCC | 36.38 | 29255136 | |
302 | Phosphorylation | PKPRVSDSESEGPQK CCCCCCCCCCCCCCC | 35.20 | 23401153 | |
304 | Phosphorylation | PRVSDSESEGPQKGP CCCCCCCCCCCCCCC | 52.37 | 29255136 | |
313 | Phosphorylation | GPQKGPASDSETEDA CCCCCCCCCCCCHHH | 44.81 | 29255136 | |
315 | Phosphorylation | QKGPASDSETEDASR CCCCCCCCCCHHHHH | 43.87 | 29255136 | |
317 | Phosphorylation | GPASDSETEDASRHK CCCCCCCCHHHHHHC | 43.02 | 29255136 | |
321 | Phosphorylation | DSETEDASRHKQKPE CCCCHHHHHHCCCCC | 47.44 | 23927012 | |
329 | Phosphorylation | RHKQKPESDDDSDRE HHCCCCCCCCCCCCC | 55.67 | 20164059 | |
333 | O-linked_Glycosylation | KPESDDDSDRENKGE CCCCCCCCCCCCCCC | 45.63 | 30379171 | |
333 | Phosphorylation | KPESDDDSDRENKGE CCCCCCCCCCCCCCC | 45.63 | 20164059 | |
342 | Phosphorylation | RENKGEDTEMQNDSF CCCCCCCCCCCCCCC | 29.11 | 28102081 | |
348 | Phosphorylation | DTEMQNDSFHSDSHM CCCCCCCCCCCCCHH | 32.20 | 27362937 | |
351 | Phosphorylation | MQNDSFHSDSHMDRK CCCCCCCCCCHHCHH | 38.51 | 27362937 | |
353 | Phosphorylation | NDSFHSDSHMDRKKF CCCCCCCCHHCHHHH | 24.59 | 28102081 | |
362 | Phosphorylation | MDRKKFHSSDSEEEE HCHHHHCCCCCHHHH | 38.69 | 29255136 | |
363 | Phosphorylation | DRKKFHSSDSEEEEH CHHHHCCCCCHHHHH | 36.26 | 29255136 | |
365 | Phosphorylation | KKFHSSDSEEEEHKK HHHCCCCCHHHHHHH | 49.18 | 29255136 | |
377 | Phosphorylation | HKKQKMDSDEDEKEG HHHHHCCCHHHHHHC | 39.13 | 29255136 | |
398 | Phosphorylation | KRKAAVLSDSEDEEK HHHHHHHCCCCHHHH | 32.27 | 29255136 | |
400 | Phosphorylation | KAAVLSDSEDEEKAS HHHHHCCCCHHHHHH | 43.50 | 29255136 | |
405 | Ubiquitination | SDSEDEEKASAKKSR CCCCHHHHHHHHHCC | 45.66 | 24816145 | |
407 | Phosphorylation | SEDEEKASAKKSRVV CCHHHHHHHHHCCCC | 52.25 | 23927012 | |
409 | Acetylation | DEEKASAKKSRVVSD HHHHHHHHHCCCCCC | 49.11 | 19829111 | |
410 | Ubiquitination | EEKASAKKSRVVSDA HHHHHHHHCCCCCCC | 43.12 | 24816145 | |
411 | Phosphorylation | EKASAKKSRVVSDAD HHHHHHHCCCCCCCC | 29.60 | 30576142 | |
415 | Phosphorylation | AKKSRVVSDADDSDS HHHCCCCCCCCCCCC | 24.99 | 29255136 | |
420 | Phosphorylation | VVSDADDSDSDAVSD CCCCCCCCCCCCCCC | 39.29 | 29255136 | |
422 | Phosphorylation | SDADDSDSDAVSDKS CCCCCCCCCCCCCCC | 31.27 | 29255136 | |
426 | Phosphorylation | DSDSDAVSDKSGKRE CCCCCCCCCCCCCCC | 40.83 | 29255136 | |
429 | Phosphorylation | SDAVSDKSGKREKTI CCCCCCCCCCCCCCC | 55.31 | 26055452 | |
434 | Acetylation | DKSGKREKTIASDSE CCCCCCCCCCCCCCH | 49.63 | 6508079 | |
435 | Phosphorylation | KSGKREKTIASDSEE CCCCCCCCCCCCCHH | 19.61 | 22167270 | |
438 | Phosphorylation | KREKTIASDSEEEAG CCCCCCCCCCHHHHH | 37.51 | 29255136 | |
440 | Phosphorylation | EKTIASDSEEEAGKE CCCCCCCCHHHHHHH | 44.40 | 29255136 | |
449 | Phosphorylation | EEAGKELSDKKNEEK HHHHHHHHHHHHHHH | 48.77 | 23927012 | |
461 | Phosphorylation | EEKDLFGSDSESGNE HHHCCCCCCCCCCCH | 30.54 | 29997176 | |
463 | Phosphorylation | KDLFGSDSESGNEEE HCCCCCCCCCCCHHH | 35.05 | 29997176 | |
465 | Phosphorylation | LFGSDSESGNEEENL CCCCCCCCCCHHHCH | 51.36 | 29997176 | |
480 | Phosphorylation | IADIFGESGDEEEEE HHHHHCCCCCHHHHH | 52.50 | 26074081 | |
489 | Phosphorylation | DEEEEEFTGFNQEDL CHHHHHHCCCCHHHH | 44.11 | 29997176 | |
503 | Phosphorylation | LEEEKGETQVKEAED HHHHHCCCCCCCCCC | 47.53 | 28634120 | |
511 | Phosphorylation | QVKEAEDSDSDDNIK CCCCCCCCCCCCCCH | 30.44 | 29255136 | |
513 | Phosphorylation | KEAEDSDSDDNIKRG CCCCCCCCCCCCHHH | 51.30 | 29255136 | |
518 | Ubiquitination | SDSDDNIKRGKHMDF CCCCCCCHHHHHHHH | 62.44 | - | |
521 | Ubiquitination | DDNIKRGKHMDFLSD CCCCHHHHHHHHHHH | 39.53 | - | |
527 | Phosphorylation | GKHMDFLSDFEMMLQ HHHHHHHHHHHHHHH | 40.00 | 27422710 | |
532 | Ubiquitination | FLSDFEMMLQRKKSM HHHHHHHHHHHHHHH | 1.96 | 24816145 | |
551 | Phosphorylation | RRNRDGGTFISDADD CCCCCCCCCCCCHHH | 24.27 | 29116813 | |
554 | Phosphorylation | RDGGTFISDADDVVS CCCCCCCCCHHHHHH | 23.66 | 29116813 | |
560 | Ubiquitination | ISDADDVVSAMIVKM CCCHHHHHHHHHHHH | 3.77 | 21890473 | |
560 (in isoform 2) | Ubiquitination | - | 3.77 | 21890473 | |
560 (in isoform 3) | Ubiquitination | - | 3.77 | 21890473 | |
576 | Ubiquitination | EAAEEDRQLNNQKKP HHHHHHHHHHHCCCH | 61.95 | 24816145 | |
589 | Phosphorylation | KPALKKLTLLPAVVM CHHHHHHCHHHHHHH | 34.82 | 20068231 | |
600 | Acetylation | AVVMHLKKQDLKETF HHHHHHHHHHHHHHH | 56.24 | 20167786 | |
604 | Acetylation | HLKKQDLKETFIDSG HHHHHHHHHHHHHHH | 64.10 | 20167786 | |
606 | Phosphorylation | KKQDLKETFIDSGVM HHHHHHHHHHHHHHH | 25.05 | 28387310 | |
610 | Phosphorylation | LKETFIDSGVMSAIK HHHHHHHHHHHHHHH | 28.59 | 28387310 | |
614 | Phosphorylation | FIDSGVMSAIKEWLS HHHHHHHHHHHHHHC | 25.16 | 28387310 | |
621 | Phosphorylation | SAIKEWLSPLPDRSL HHHHHHHCCCCCCCC | 26.01 | 21815630 | |
626 | Methylation | WLSPLPDRSLPALKI HHCCCCCCCCCHHHH | 37.85 | 115480703 | |
632 | 2-Hydroxyisobutyrylation | DRSLPALKIREELLK CCCCCHHHHHHHHHH | 41.65 | - | |
653 | Acetylation | SVSQETLKHSGIGRA CCCHHHHHHCCCCHH | 43.05 | 25953088 | |
712 | Sulfoxidation | EQRDLEQMPQRRRMN HHHHHHHCHHHHHHH | 1.92 | 21406390 | |
720 | Phosphorylation | PQRRRMNSTGGQTPR HHHHHHHCCCCCCCH | 21.06 | 29255136 | |
721 | Phosphorylation | QRRRMNSTGGQTPRR HHHHHHCCCCCCCHH | 40.08 | 27273156 | |
725 | Phosphorylation | MNSTGGQTPRRDLEK HHCCCCCCCHHHHHH | 23.26 | 23401153 | |
739 | Acetylation | KVLTGEEKALRPGDP HHHCCCHHHCCCCCC | 48.71 | 25953088 | |
739 | Ubiquitination | KVLTGEEKALRPGDP HHHCCCHHHCCCCCC | 48.71 | 24816145 | |
744 | Ubiquitination | EEKALRPGDPGFCAR CHHHCCCCCCCCCCE | 47.51 | 24816145 | |
762 | Phosphorylation | PMPSNKDYVVRPKWN CCCCCCCCEECCCCC | 11.49 | - | |
767 | Acetylation | KDYVVRPKWNVEMES CCCEECCCCCEEECC | 40.61 | 25953088 | |
767 | Ubiquitination | KDYVVRPKWNVEMES CCCEECCCCCEEECC | 40.61 | 22817900 | |
767 (in isoform 1) | Ubiquitination | - | 40.61 | 21890473 | |
772 | Ubiquitination | RPKWNVEMESSRFQA CCCCCEEECCCHHHC | 5.43 | 21890473 | |
782 | 2-Hydroxyisobutyrylation | SRFQATSKKGISRLD CHHHCCCHHHHHHHH | 51.14 | - | |
782 | Acetylation | SRFQATSKKGISRLD CHHHCCCHHHHHHHH | 51.14 | 25953088 | |
783 | Methylation | RFQATSKKGISRLDK HHHCCCHHHHHHHHH | 62.33 | 116253573 | |
783 | Ubiquitination | RFQATSKKGISRLDK HHHCCCHHHHHHHHH | 62.33 | 24816145 | |
788 | Ubiquitination | SKKGISRLDKQMRKF CHHHHHHHHHHHHHH | 8.45 | 24816145 | |
794 | Methylation | RLDKQMRKFTDIRKK HHHHHHHHHHHHHHH | 47.47 | 115971569 | |
796 | Phosphorylation | DKQMRKFTDIRKKSR HHHHHHHHHHHHHHC | 33.29 | 24719451 | |
811 | Phosphorylation | SAHAVKISIEGNKMP CCCEEEEEEECCCCC | 14.63 | 28555341 | |
816 | Ubiquitination | KISIEGNKMPL---- EEEEECCCCCC---- | 53.39 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IWS1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IWS1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SPT6H_HUMAN | SUPT6H | physical | 19141475 | |
SETD2_HUMAN | SETD2 | physical | 19141475 | |
RPB1_HUMAN | POLR2A | physical | 19141475 | |
STAT2_HUMAN | STAT2 | physical | 21988832 | |
ERIC2_HUMAN | ERICH2 | physical | 25416956 | |
KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
CTR9_HUMAN | CTR9 | physical | 26344197 | |
PRCC_HUMAN | PRCC | physical | 26496610 | |
SPT5H_HUMAN | SUPT5H | physical | 26496610 | |
CTDP1_HUMAN | CTDP1 | physical | 26496610 | |
BRE1B_HUMAN | RNF40 | physical | 26496610 | |
ACTZ_HUMAN | ACTR1A | physical | 26496610 | |
SF3B5_HUMAN | SF3B5 | physical | 26496610 | |
DAB2P_HUMAN | DAB2IP | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287; SER-289; SER-315;SER-398; SER-400; THR-435; SER-438 AND SER-440, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159; SER-170;SER-172; SER-300; SER-302; SER-304; SER-313; SER-315; SER-398;SER-400; THR-435; SER-438 AND SER-440, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398; SER-400; SER-438AND SER-440, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-69; SER-80; SER-82;SER-276; SER-278; SER-287; SER-289; SER-313; SER-315; SER-377;SER-398; SER-400; SER-407; SER-415; SER-420; SER-422; SER-426;SER-429; SER-438; SER-440; SER-511 AND SER-513, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-400, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-274, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398; SER-400; SER-438AND SER-440, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-274; SER-276; SER-313;SER-315; SER-398; SER-400; SER-407; SER-438 AND SER-440, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-133; SER-144;SER-146; SER-157; SER-159; SER-248; SER-250; SER-261; SER-263;SER-274; SER-276; SER-287; SER-289; SER-313; SER-315; SER-329;SER-333; SER-362; SER-363; SER-365; SER-377; SER-398; SER-400;SER-415; SER-420; SER-422; SER-426; SER-438; SER-440; SER-461;SER-463; SER-465; SER-480; SER-511 AND SER-513, AND MASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398 AND SER-400, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-170; SER-183;SER-185; SER-222; SER-224; SER-287; SER-289; SER-315; SER-398;SER-400; SER-422; SER-426; SER-438 AND SER-440, AND MASS SPECTROMETRY. |